Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
250 participants
OBSERVATIONAL
2025-01-05
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Design:
This is an observational, cross-sectional study aimed at investigating the prevalence of musculoskeletal disorders (MSDs) and associated risk factors among Egyptian students enrolled in the Faculty of Applied Arts during their last three academic years. The study will collect demographic data (age, gender) and assess musculoskeletal symptoms using the Nordic Musculoskeletal Questionnaire (NMQ-E).
Study Population:
The target population includes approximately 9,600 students from the Faculty of Applied Arts in Egypt. A sample of 250 participants will be recruited based on eligibility criteria.
Inclusion Criteria:
Egyptian students from the Faculty of Applied Arts. Age range: 20-22 years. Both genders included.
Exclusion Criteria:
Obesity. Pregnancy. History of neuropathy or other neurological disorders such as lumbar plexopathy, spinal stenosis, and nerve root compression.
Unstable medical conditions. History of central nervous system malignancy (primary or metastatic). Musculoskeletal problems due to trauma or previous surgery.
Sample Size Calculation:
The sample size was determined using a sample size calculator with a confidence interval of 95% and α level of 0.05. From a population of 9,600, a minimum of 250 participants was required to achieve statistical power.
Instrumentations:
The Arabic version of the extended Nordic Musculoskeletal Questionnaire (NMQ-E) will be utilized. The NMQ is a validated tool for assessing musculoskeletal symptoms, including pain prevalence and anatomical distribution.
Key Sections of NMQ-E:
Section 1: 40 forced-choice items identifying musculoskeletal problem areas, supported by a body map. Symptoms over the last 12 months and the past 7 days will be evaluated.
Section 2: Additional questions on neck, shoulders, and lower back, covering symptom duration, functional impact, professional assessments, and recent musculoskeletal problems.
Procedure:
Participants will be recruited from the Faculty of Applied Arts and asked to complete the NMQ-E online or in person. Data on musculoskeletal symptoms and ergonomic practices will be collected over a specific timeframe.
Validity and Reliability of NMQ-E:
Validity:
Content validity is supported by expert review and alignment with established measures of musculoskeletal health.
Criterion validity demonstrated strong correlations between NMQ responses and clinical assessments (sensitivity: 66-92%; specificity: 71-88%).
Reliability:
High test-retest reliability observed in various populations. Internal consistency confirmed via Cronbach's alpha.
Data Analysis and Statistical Design:
The collected data will be analyzed using statistical software, employing:
Descriptive statistics (mean, standard deviation, percentages). Statistical significance set at p \< 0.05.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arabic version of The Nordic Musculoskeletal Questionnaire (NMQ) is a standardized questionnaire used to assess musculoskeletal symptoms and disorders in the workplace
The Nordic Musculoskeletal Questionnaire (NMQ) is a standardized questionnaire used to assess musculoskeletal symptoms and disorders in the workplace. It is commonly used in occupational health and ergonomic assessments to gather information about the prevalence and severity of musculoskeletal issues such as pain, discomfort, and limitations in movement. The NMQ typically includes questions about specific body regions (e.g. neck, shoulders, back, wrists) and asks individuals to report any symptoms they may be experiencing in those areas. This information can help identify potential risk factors for musculoskeletal disorders and guide interventions to prevent or manage these conditions in the workplace (Namnik et al., 2016).
• Section 1: a general questionnaire of 40 forced-choice items identifying areas of the body causing musculoskeletal problems. Completion is aided by a body map to indicate nine symptom sites being neck, shoulders, upper back, elbows, low back, wrist/hands, hips/thi
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age (20-22) years old
3. both genders will be included.
Exclusion Criteria
2. Pregnancy.
3. Patients who had history of any other neuropathy.
4. Unstable medical condition.
5. Other neurological disorders causing pain as lumbar plexopathy, spinal stenosis, and spinal nerve root compression.
6. History of central nervous system primary or metastatic malignancy
7. student having any musculoskeletal problems due to other causes as accidents or a previous operation.
20 Years
22 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Osama Abdelaziz
physical therapy practitioner
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/005019
Identifier Type: -
Identifier Source: org_study_id